Il progesterone e il 17α-idrossiprogesterone caproato- a review
Il progesterone (P) c utilizzato in un gran numero di indicazioni terapeutiche quali disordini mestruali, incluse amenorrea secondaria, disordini mestruali premenopausali, supporto della fase luteale, minaccia di aborto, parto pretermine (Carr and Wilson, 1994; Withehead et al., 1990). fl l 7a-idrossiprogesterone, senza esterificazione. non possiede attività progestativa (Junkmann, 1954; Pfiffner and North, 1941) ma i …
MoreMyo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles
Objective: To determine the effects of myo-inositol on oocyte quality in polycystic ovary syndrome (PCOS) patients undergoing intracytoplasmic sperm injection (ICSI) cycles. Design: A prospective, controlled, randomized trial. Setting: Assisted reproduction centers. Patient(s): Sixty infertile PCO patients undergoing ovulation induction for ICSI.
Intervention(s): All participants underwent standard long protocol. Starting on the …
MoreTreatment of hirsutism with myo-inositol: a prospective clinical study.
The aim of this study was to evaluate the effects of myo-inositol treatment in hirsute women; changes in lipid pattern and insulin sensitivity were also considered.
Scarica il documento (PDF)
MoreTreatment of hirsutism with myo-inositol
The aim of this study was to evaluate the effects of myo-inositol treatment in hirsute women; changes in lipid pattern and insulin sensitivity were also considered. Forty-six hirsute women were enrolled at the first Institute of Obstetrics and Gynecology and evaluated at baseline and after receiving myo-inositol therapy for 6 months. Body mass …
MoreOdontostomatological approach to pregnant patient
Pregnancy is a condition characterized by various physiological modifications (placentary and ovarian hormones release) that influence various organic districts, including the oral district. In this review were re-examined the rules about the execution of dental services with the relative indications and contraindications during the different phases of pregnancy, the use of the ionizing …
MoreMyo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction
Background. Polycystic ovary syndrome (PCOS) is often characterized by chronic oligo- or anovulation (usually manifested as oligo- or amenorrhea), and hyperandrogenism. In addition, 30–40% of PCOS women have impaired glucose tolerance, and a defect in the insulin signaling pathway (inositol-containing phosphoglycan mediators) seems to be implicated in the pathogenesis of insulin resistance. PCOS …
MoreThe Use of Progesterone in Clinical Practice Evaluation of its Efficacy in Diverse Indications
Introduction: Progesterone is a hormone of paramount importance in the reproductive physiology. Its multiple physiological roles and pharmacology have been extensively studied throughout the years. However, the use of progesterone in the pathophysiology of pregnancy as well as in its other indications remains arguable for diverse reasons. One of these reasons concerns the …
MoreThe Use of Progesterone in Clinical Practice: Evaluation of its Efficacy in Diverse Indications Using Different Routes of Administration
Introduction: Progesterone is a hormone of paramount importance in the reproductive physiology. Its multiple physiological roles and pharmacology have been extensively studied throughout the years. However, the use of progesterone in the pathophysiology of pregnancy as well as in its other indications remains arguable for diverse reasons. One of these reasons concerns the …
MorePsychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study
Objective: To investigate the effects of soy isoflavones on mood and cognitive function in postmenopausal women.
Design: Randomized, double-blind, cross-over, placebo-controlled trial.
Setting: University Hospital, Milan, Italy; A.G.UN.CO. Obstetrics and Gynaecology Centre, Rome, Italy.
Patient(s): Seventy-eight postmenopausal women. Intervention(s): We administered 60 mg/day isoflavones or placebo for 6 months. After a washout period of 1 month, the patients …
More